255 related articles for article (PubMed ID: 3811647)
1. [Renal osteodystrophy].
Schober HC
Z Urol Nephrol; 1986 Oct; 79(10):595-602. PubMed ID: 3811647
[No Abstract] [Full Text] [Related]
2. Renal osteodystrophy in children on maintenance haemodialysis.
Mehls O; Krempien B; Ritz E; Schärer K; Schüler HW
Proc Eur Dial Transplant Assoc; 1973; 10(0):197-201. PubMed ID: 4802577
[No Abstract] [Full Text] [Related]
3. [Management of renal osteopathy in patients with chronic dialysis].
Kiss D; Brunner FP
Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
[No Abstract] [Full Text] [Related]
5. Diseases of the urinary system. renal osteodystrophy.
Hosking DJ
Br Med J; 1977 Jul; 2(6079):110-2. PubMed ID: 871770
[No Abstract] [Full Text] [Related]
6. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
7. Renal osteodystrophy.
Coburn JW; Henry DA
Adv Intern Med; 1984; 30():387-424. PubMed ID: 6397042
[TBL] [Abstract][Full Text] [Related]
8. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy.
Gonzalez MT; Gonzalez C; Griñó JM; Castelao AM; Mariñoso ML; Serrano S; Bonnin R; Carreras L; Alsina J
Transplant Proc; 1990 Aug; 22(4):1407-11. PubMed ID: 2389341
[No Abstract] [Full Text] [Related]
9. Comparison of biochemical with radiological findings in renal osteodystrophy.
Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Wills MR
Ann Clin Biochem; 1975 May; 12(3):126-31. PubMed ID: 15637920
[TBL] [Abstract][Full Text] [Related]
10. Renal osteodystrophy in children: pathogenesis, diagnosis and treatment.
Kemper MJ; van Husen M
Curr Opin Pediatr; 2014 Apr; 26(2):180-6. PubMed ID: 24553631
[TBL] [Abstract][Full Text] [Related]
11. Histological, hormonal, biochemical and radiological evaluation of vit. D therapy in osteodystrophy patients on RDT.
Brancaccio D; Graziani G; Faccini JM; Banfi G; Pedoja G; Watson L
J Urol Nephrol (Paris); 1976; 82(4-5):359-62. PubMed ID: 940182
[No Abstract] [Full Text] [Related]
12. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.
Martin KJ; Olgaard K; Coburn JW; Coen GM; Fukagawa M; Langman C; Malluche HH; McCarthy JT; Massry SG; Mehls O; Salusky IB; Silver JM; Smogorzewski MT; Slatopolsky EM; McCann L;
Am J Kidney Dis; 2004 Mar; 43(3):558-65. PubMed ID: 14981615
[No Abstract] [Full Text] [Related]
14. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
Offermann G; Schaefer K; Schulz A; Delling G
Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
[TBL] [Abstract][Full Text] [Related]
15. Assessment of renal osteodystrophy following renal transplantation.
Pierides AM; Ellis HA; Peart KM; Simpson W; Uldall PR; Kerr DN
Proc Eur Dial Transplant Assoc; 1975; 11():481-7. PubMed ID: 1105559
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D therapy in CAPD: what is its role?
Hutchison AJ; Gokal R
Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH.
Ritz E; Malluche HH; Krempien B; Tschope W; Massry SG
Adv Exp Med Biol; 1978; 103():423-36. PubMed ID: 362849
[No Abstract] [Full Text] [Related]
18. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
Bordier PJ; Marie PJ; Arnaud CD
Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
[No Abstract] [Full Text] [Related]
19. Treatment of renal osteodystrophy in advanced renal failure during predialysis time.
Fröhling PT; Kokot F; Vetter K; Hohmann WD; Werner G; Grossmann I; Schmicker R; Lindenau K
Contrib Nephrol; 1984; 37():62-5. PubMed ID: 6609046
[No Abstract] [Full Text] [Related]
20. The CARI guidelines. Biochemical targets.
Hawley C; Elder G;
Nephrology (Carlton); 2006 Apr; 11 Suppl 1():S198-216. PubMed ID: 16684076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
